Single-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.

被引：0
|
作者：
Bartlett, M. [1 ]
Vaidyanathan, S. [2 ]
Karan, R. S. [2 ]
Hu, P. [3 ]
Howard, D. [4 ]
Yeh, C. M. [4 ]
Dieterich, H. A. [1 ]
Al-Fayoumi, S. [4 ]
Jarugula, V. [4 ]
Doles, W. P. [5 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Private Ltd, Hyderabad, Andhra Pradesh, India
[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[4] Nova Pharmaceut Corp, E Hanover, NJ USA
[5] Novartis Inst Biomed Res Inc, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [31] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Liang, Beibei
    Wang, Jin
    Zhang, Guanxuanzi
    Wang, Rui
    Cai, Yun
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 947 - 959
  • [32] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Beibei Liang
    Jin Wang
    Guanxuanzi Zhang
    Rui Wang
    Yun Cai
    Neurology and Therapy, 2023, 12 : 947 - 959
  • [33] Aliskiren, an orally effective renin inhibitor, shows dose linear pharmacokinetics in healthy volunteers.
    Vaidyanathan, S
    Limoges, D
    Yeh, C
    Dieterich, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P64 - P64
  • [34] Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects
    Hu, Pei
    Jiang, Ji
    Wang, Hongyun
    Pietropaolo, Keith
    Chao, George C.
    Brown, Nathaniel A.
    Zhou, Xiao-Jian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 999 - 1007
  • [35] A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects
    Ayalasomayajula, Surya
    Tchaloyan, Stephanie
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 717 - 726
  • [36] A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects
    Vaidyanathan, Sujata
    Maboudian, Mojdeh
    Warren, Vance
    Yeh, Ching-Ming
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) : 2313 - 2326
  • [37] EFFECT OF MORICIZINE ON THE PHARMACOKINETICS OF SINGLE-DOSE THEOPHYLLINE IN HEALTHY-SUBJECTS
    PIENIASZEK, HJ
    DAVIDSON, AF
    BENEDEK, IH
    THERAPEUTIC DRUG MONITORING, 1993, 15 (03) : 199 - 203
  • [38] Effect of age and gender on single-dose pharmacokinetics of entecavir in healthy subjects
    Yan, JH
    Bifano, M
    Xie, J
    Zhang, D
    Grasela, D
    LaCreta, F
    ANTIVIRAL THERAPY, 2004, 9 (06) : H23 - H23
  • [39] The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects
    Huiping Xu
    Melissa O’Gorman
    Weiwei Tan
    Nicoletta Brega
    Akintunde Bello
    European Journal of Clinical Pharmacology, 2015, 71 : 1441 - 1449
  • [40] The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects
    Marino, MR
    Langenbacher, KM
    Hammett, JL
    Nichola, P
    Uderman, HD
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) : 27 - 33
12345